Teladoc Health
TDOC
552 hedge funds and large institutions have $4.76B invested in Teladoc Health in 2022 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 205 increasing their positions, 178 reducing their positions, and 186 closing their positions.
15% more repeat investments, than reductions
Existing positions increased: 205 | Existing positions reduced: 178
1.52% more ownership
Funds ownership: 86.84% → 88.36% (+1.5%)
8% more call options, than puts
Call options by funds: $407M | Put options by funds: $378M
3% more capital inflows, than outflows
Capital inflows: $1.13B | Capital outflows: $1.1B
19% less funds holding
Funds holding: 681 → 552 (-129)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
63% less first-time investments, than exits
New positions opened: 68 | Existing positions closed: 186
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$171M |
| 2 |
State of Michigan Retirement System
Lansing,
Michigan
|
+$157M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$97.7M |
| 4 |
Two Sigma Investments
New York
|
+$90.7M |
| 5 |
D.E. Shaw & Co
New York
|
+$70.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$127M |
| 2 |
Bank of New York Mellon
New York
|
-$90.7M |
| 3 |
JP Morgan Chase
New York
|
-$72.5M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$64.2M |
| 5 |
Gilder Gagnon Howe & Co
New York
|
-$62.8M |
TDOC Hedge Fund Activity: Q2 2022 in Review
552 of the 5,963 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q2 2022, worth a combined $4.76B — down 53% from $10B a quarter earlier.
Sellers outnumbered buyers: 186 funds closed out of TDOC and 68 opened new positions — a net loss of 118 holders — while 178 trimmed existing stakes and 205 added.
The largest buyer was Renaissance Technologies, adding an estimated $171M. The largest seller was Baillie Gifford & Co, cutting an estimated $127M.
- 552 institutional investors held Teladoc Health (TDOC) as of Q2 2022, down from 681 in Q1 2022.
- Funds reported $4.76B of Teladoc Health stock for Q2 2022, down 53% quarter-over-quarter.
- 68 funds opened new Teladoc Health positions in Q2 2022 and 186 closed out, a net change of -118 holders.
- The largest Teladoc Health buyer in Q2 2022 was Renaissance Technologies, an estimated $171M added.
- The largest Teladoc Health seller in Q2 2022 was Baillie Gifford & Co, an estimated $127M sold.
Based on aggregated 13F filings for Q2 2022.